Economic evaluations of psychological treatments for common mental disorders in low- and middle-income countries: protocol for a systematic review

References

• The WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. J Am Med Assoc. 2004;291:2581–12.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s world mental health survey initiative. World Psychiatry. 2007;6:168–176.
   PubMed Web of Science ®Google Scholar
• Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43:476–493.
   PubMed Web of Science ®Google Scholar
• Herman AA, Stein DJ, Seedat S, et al. The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J. 2009;99:339–344.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Depression and other common mental disorders global health estimates. Geneva: WHO: Global Health Estimates; 2017.
   Google Scholar
• Sagar R, Pattanayak RD, Chandrasekaran R, et al. Twelve‑month prevalence and treatment gap for common mental disorders: findings from a large‑scale epidemiological survey in India. Indian J Psychiatry. 2017;59:46–55.
   Web of Science ®Google Scholar
• Myers B, Lund C, Lombard C, et al. Comparing dedicated and designated models of integrating mental health into chronic disease care : study protocol for a cluster randomized controlled trial. Trials. 2018;19:1–13.
   Google Scholar
• Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet [Internet]. 2013;382:1575–1586.
   PubMed Web of Science ®Google Scholar
• Patel V, Chisholm D, Dua T, et al. Disease control priorities, Third Edition (Volume 4): mental, neurological, and substance use disorders. Vol. 4, disease control priorities, Third Edition (Volume 4): mental. Washington D.C: Neurological, and Substance Use Disorders; 2016.
   Google Scholar
• World Health Organization (WHO). Global health estimates 2019: disease burden by cause, age, sex, by country and by region, 2000-2019. Geneva; 2020.
   Google Scholar
• Bloom DE, Cafiero E, Jané-Llopis E, et al. The global economic burden of noncommunicable diseases [Internet]. Geneva: World Health Organization; 2011. Available from: http://ideas.repec.org/p/gdm/wpaper/8712.html
   Google Scholar
• Knapp M, Wong G. Economics and mental health: the current scenario. World Psychiatry. 2020;19:3–14.
   PubMed Web of Science ®Google Scholar
• World Health Organization, United Nations High Commissioner for Refugees. mhGAP Humanitarian Intervention Guide (mhGAP-HIG): clinical management of mental, neurological and substance use conditions in humanitarian emergencies. Mental Health Gap Action Program. 2015.
   Google Scholar
• Cuijpers P, Hollon SD, Van Straten A, et al. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open. 2013;3:1–8.
   Web of Science ®Google Scholar
• McBain R, Salhi C, Morris JE, et al. Disease burden and mental health system capacity: WHO Atlas study of 117 low- and middle-income countries. Br J Psychiatry. 2012;201:444–450.
   Web of Science ®Google Scholar
• Jack H, Wagner GRG, Petersen I, et al. Closing the mental health treatment gap in South Africa: a review of costs and cost-effectiveness. Glob Health Action. 2014;7:1–11.
   Web of Science ®Google Scholar
• Singla DR, Kohrt BA, Murray LK, et al. Psychological treatments for the world: lessons from low- and middle-income countries. Annu Rev Clin Psychol. 2017;13:149–181.
   PubMed Web of Science ®Google Scholar
• Eaton J, McCay L, Semrau M, et al. Scale up of services for mental health in low-income and middle-income countries. Lancet [Internet]. 2011;378:1592–1603.
   PubMed Web of Science ®Google Scholar
• Chisholm D, Sweeny K, Sheehan P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry [Internet]. 2016;3:415–424.
   PubMed Web of Science ®Google Scholar
• van Ginneken N, Tharyan P, Lewin S, et al. Non-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countries. Cochrane Database Syst Rev [Internet]. 2013;11:CD009149. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24249541
   PubMed Web of Science ®Google Scholar
• Kok JLA, Williams A, Zhao L. Psychosocial interventions for people with diabetes and co-morbid depression. A systematic review. Int J Nurs Stud [Internet]. 2015;52:1625–1639.
   Web of Science ®Google Scholar
• Ho FYY, Yeung WF, Ng THY, et al. The efficacy and cost-effectiveness of stepped care prevention and treatment for depressive and/or anxiety disorders: a systematic review and meta-analysis. Sci Rep [Internet]. 2016;6:1–10.
   PubMed Web of Science ®Google Scholar
• De Sousa A, Mohandas E, Javed A. Psychological interventions during COVID-19: challenges for low and middle income countries. Asian J Psychiatr [Internet]. 2020;51:102128.
   PubMed Web of Science ®Google Scholar
• Arjadi R, Nauta MH, Chowdhary N, et al. A systematic review of online interventions for mental health in low and middle income countries: a neglected field. Glob Ment Heal. 2015;2:0–5.
   Web of Science ®Google Scholar
• Bockting CLH, Williams AD, Carswell K, et al. The potential of low-intensity and online interventions for depression in low- and middle-income countries. Global Mental Health. 2016;3;e25.
   Web of Science ®Google Scholar
• Naslund J, Aschbrenner K, Araya R, et al. Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature. Lancet Psychiatry. 2017;4:486–500.
   PubMed Web of Science ®Google Scholar
• Chisholm D, Flisher A, Lund C, et al. Scale up services for mental disorders: a call for action. Lancet. 2007;370:1241–1252.
   PubMed Web of Science ®Google Scholar
• WHO/UNDP. Making the investment case for mental health: a WHO/UNDP methodological guidance note [Internet]. Geneva; 2019. Available from: http://apps.who.int/bookorders
   Google Scholar
• Patel V. The need for treatment evidence for common mental disorders in developing countries. Psychol Med. 2000;30:743–746.
   PubMed Web of Science ®Google Scholar
• Levin C, Chisholm D. Cost-effectiveness and affordability of interventions, policies, and platforms for the prevention and treatment of mental, neurological, and substance use disorders. In: Patel V, Chisholm D, Dua T, et al., editors. Mental, neurological, and substance use disorders: disease control priorities. 3rd ed. Washington D.C;The World Bank; 2016. p. 219–236. doi: https://doi.org/10.1017/CBO9781107415324.004.
   Google Scholar
• Hauck K, Smith PC, Goddard M. 2004. The economics of priority setting for health care: a literature review [Internet]. Washington D.C: The World Bank. Available from: http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2005/02/04/000112742_20050204160727/Rendered/PDF/288780revised0.pdf
   Google Scholar
• Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmmes. 4th ed. Oxford: Oxford University Press; 2015.
   Google Scholar
• Lund C, Orkin K, Witte M, et al. Economic impacts of mental health interventions in low and middle-income countries: a systematic review and meta-analysis. Working paper.
   Google Scholar
• Sun Y, Wong SYS, Zhang D, et al. Behavioral activation with mindfulness in treating subthreshold depression in primary care: a cost-utility and cost-effectiveness analysis alongside a randomized controlled trial. J Psychiatr Res [Internet]. 2021;132:111–115.
   Web of Science ®Google Scholar
• Siskind D, Araya R, Kim J. Cost-effectiveness of improved primary care treatment of depression in women in Chile. Br J Psychiatry. 2010;197:291–296.
   Web of Science ®Google Scholar
• Strand KB, Chisholm D, Fekadu A, et al. Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis. Health Policy Plan. 2016;31:504–513.
   PubMed Web of Science ®Google Scholar
• Iijima S, Yokoyama K, Kitamura F, et al. Cost-benefit analysis of comprehensive mental health prevention programs in Japanese workplaces: a pilot study. Ind Health. 2013;51:627–633.
   Web of Science ®Google Scholar
• Layard R, Clark D, Knapp M, et al. Cost-benefit analysis of psychological therapy. Natl Inst Econ Rev. 2007;202:90–98.
   Google Scholar
• McDaid D. Making the long-term economic case for investing in mental health to contribute to sustainability from a health, public sector and societal perspective [Internet]. Brussels: European Union: (IMPACT) European Pact for Mental Health and Well-being Summary; 2011. Available from: http://eprints.lse.ac.uk/41901/
   Google Scholar
• Chisholm D, Samantha C. Return on investment in global mental health innovation : a primer. Geneva: Mental Health Innovation Network (MHIN); 2016.
   Google Scholar
• McCrone P, Weich S. Mental health care costs: paucity of measurement. Soc Psychiatry Psychiatr Epidemiol. 1996;31:70–77.
   PubMed Web of Science ®Google Scholar
• Churchill R, Hunot V, Corney R, et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess (Rockv) [Internet]. 2002;5:1–173. Available from: http://gala.gre.ac.uk/4982/1/summ535.pdf
   Google Scholar
• Mitchell LM, Vella-Brodrick D, Klein B. Economic evaluations of Internet-based psychological therapies for anxiety disorders and depression: a systematic literature review. J Affect Disord [Internet]. 2021;284:157–182.
   Web of Science ®Google Scholar
• Donker T, Blankers M, Hedman E, et al. Economic evaluations of Internet interventions for mental health: a systematic review. Psychol Med. 2015;45:3357–3376.
   PubMed Web of Science ®Google Scholar
• von der Warth R, Dams J, Grochtdreis T, et al. Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. Eur J Psychotraumatol [Internet]. 2020;11. DOI:https://doi.org/10.1080/20008198.2020.1753940.
   Google Scholar
• Ophuis RH, Lokkerbol J, Heemskerk SCM, et al. Cost-effectiveness of interventions for treating anxiety disorders: a systematic review. J Affect Disord. 2017;210:1–13.
   PubMed Web of Science ®Google Scholar
• Grochtdreis T, Brettschneider C, Wegener A, et al. Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review. PLoS One [Internet]. 2015;10:e0123078.
   Web of Science ®Google Scholar
• Brettschneider C, Djadran H, Härter M, et al. Cost-utility analyses of cognitive-behavioural therapy of depression: a systematic review. Psychother Psychosom. 2015;84:6–21.
   Web of Science ®Google Scholar
• Ahern E, Kinsella S, Semkovska M. Clinical efficacy and economic evaluation of online cognitive behavioral therapy for major depressive disorder: a systematic review and meta-analysis. Expert Rev Pharmacoeconomics Outcomes Res [Internet]. 2018;18:25–41.
   PubMed Web of Science ®Google Scholar
• Bosmans JE, van Schaik DJF, de Bruijne MC, et al. Are psychological treatments for depression in primary care cost-effective? J Ment Health Policy Econ. 2008;11:3–15.
   Web of Science ®Google Scholar
• van Steenbergen-Weijenburg KM, Van Der Feltz-Cornelis CM, Horn EK, et al. Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review. BMC Health Serv Res. 2010;10:19.
   Web of Science ®Google Scholar
• Kim DD, Silver MC, Kunst N, et al. Perspective and costing in cost-effectiveness analysis, 1974–2018. Pharmacoeconomics [Internet]. 2020;38:1135–1145.
   PubMed Web of Science ®Google Scholar
• Bilvick Tai BW, Bae YH, Le QA. A systematic review of health economic evaluation studies using the patient’s perspective. Value Heal [Internet]. 2016;19:903–908.
   PubMed Web of Science ®Google Scholar
• O’Mahony JF, Newall AT, van Rosmalen J. Dealing with time in health economic evaluation: methodological issues and recommendations for practice. Pharmacoeconomics. 2015;33:1255–1268.
   Web of Science ®Google Scholar
• Kim DD, Wilkinson CL, Pope EF, et al. The influence of time horizon on results of cost-effectiveness analyses. Expert Rev Pharmacoeconomics Outcomes Res [Internet]. 2017;17:615–623.
   PubMed Web of Science ®Google Scholar
• Birch S, Gafni A. Information created to evade reality (ICER): things we should not look to for answers. Pharmacoeconomics. 2006;24:1121–1131.
   PubMed Web of Science ®Google Scholar
• Barrett B, Byford S, Knapp M. Evidence of cost-effective treatments for depression: a systematic review. J Affect Disord. 2005;84:1–13.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)-explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Heal [Internet]. 2013;16:231–250.
   PubMed Web of Science ®Google Scholar
• Krol M, Papenburg J, Koopmanschap M, et al. Do productivity costs matter?: The impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. Pharmacoeconomics. 2011;29:601–619.
   PubMed Web of Science ®Google Scholar
• Byford S, Bower P. Cost-effectiveness of cognitive-behavioral therapy for depression: current evidence and future research priorities. Expert Rev Pharmacoeconomics Outcomes Res. 2002;2:457–465.
   Google Scholar
• Camacho EM, Shields GE. Cost-effectiveness of interventions for perinatal anxiety and/or depression: a systematic review. BMJ Open. 2018;8:1–10.
   Web of Science ®Google Scholar
• Patel V, Chisholm D, Parikh R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from disease control priorities, 3rd edition. Lancet. 2016;387:1672–1685.
   PubMed Web of Science ®Google Scholar
• Kaminer D, Owen M, Schwartz B. Systematic review of the evidence base for treatment of common mental disorders in South Africa. South Afr J Psychol. 2018;48:32–47.
   Web of Science ®Google Scholar
• Cubillos L, Bartels SM, Torrey WC, et al. The effectiveness and cost-effectiveness of integrating mental health services in primary care in low- and middle-income countries: systematic review. BJPsych Bull. 2021;45:40–52.
   Web of Science ®Google Scholar
• Knapp M. Economic outcomes and levers: impacts for individuals and society. Int Psychogeriatrics. 2007;19:483–495.
   Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1–9.
   PubMed Web of Science ®Google Scholar
• Akers J, Aguiar-Ibanez R, Baba-Akbari Sari A, et al. Systematic reviews: CRD’s guiance for undertaking reviewsin health care [Internet]. 3rd ed. York: University of York; 2009. Available from: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf
   Google Scholar
• Hunter R, Shearer J. Cost-consequences analysis - an underused method of economic evaluation. Natl Inst Health Res [Internet]. 2014;4–5. Available from: http://www.rds-london.nihr.ac.uk/How-to-design-a-study-find-funding/Health-economics/Cost-consequences-analysis.aspx
   Google Scholar
• Chibanda D, Cowan FM, Healy JL, et al. Psychological interventions for common mental disorders for people living with HIV in low- and middle-income countries: systematic review. Trop Med Int Heal [Internet]. 2015;20:830–839. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25753741%5Cnhttp://doi.wiley.com/10.1111/tmi.12500.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Global status report on alcohol and health 2014. 2014;1–392. Available from: http://www.who.int/substance_abuse/publications/global_alcohol_report/msbgsruprofiles.pdf
   Google Scholar
• World Bank. World Bank Country and Lending Groups [Internet]. Washington DC: World Bank; 2019. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   Google Scholar
• Endnote. San Fransisco: Endnote X7 ed; 2015.
   Google Scholar
• Drummond MF, Jefferson T. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ Br Med J. 1996;313:275–283.
   PubMed Web of Science ®Google Scholar
• Shemilt I, Mugford M, Byford S, et al. Incorporating economics evidence. In: Higgins JPT, Green SE, editors. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. West Sussex: The Cochrane Collaboration and John Wiley & Sons LTD. Published 2008.p 449-479.
   Google Scholar
• Woods B, Revill P, Sculpher M, et al. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Heal [Internet]. 2016;19:929–935.
   PubMed Web of Science ®Google Scholar
• Thokala P, Ochalek J, Leech AA, et al. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics [Internet]. 2018;36:509–522.
   PubMed Web of Science ®Google Scholar
• Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Glob Heal. 2018;3(6):e000964. doi: https://doi.org/10.1136/bmjgh-2018-000964.
   Google Scholar
• Zimovetz EA, Wolowacz SE, Classi PM, et al. Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. Cost Eff Resour Alloc. 2012;10:1–18.
   PubMedGoogle Scholar
• Cowell AJ, Bray JW, Mills MJ, et al. Conducting economic evaluations of screening and brief intervention for hazardous drinking: methods and evidence to date for informing policy. Drug Alcohol Rev. 2010;29:623–630.
   Web of Science ®Google Scholar
• Zanganeh M, Adab P, Li B, et al. A systematic review of methods, study quality, and results of economic evaluation for childhood and adolescent obesity intervention. Int J Environ Res Public Health. 2019;16:485.
   Web of Science ®Google Scholar
• Fairall L, Petersen I, Zani B, et al. Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial. Trials. 2018;19:1–24.
   Web of Science ®Google Scholar
• Mutyambizi-Mafunda V, Myers B, Sorsdahl K, et al. Integrating a brief mental health intervention into primary care services for patients with HIV and diabetes in South Africa: study protocol for a trial-based economic evaluation. BMJ Open. 2019;9:1–11.
   Web of Science ®Google Scholar
• Parikh R, Michelson D, Malik K, et al. The effectiveness of a low-intensity problem-solving intervention for common adolescent mental health problems in New Delhi, India: protocol for a school-based, individually randomized controlled trial with an embedded stepped-wedge, cluster randomized co. Trials. 2019;20:1–18.
   Web of Science ®Google Scholar
• Joag K, Kalha J, Pandit D, et al. Atmiyata, a community-led intervention to address common mental disorders: study protocol for a stepped wedge cluster randomized controlled trial in rural Gujarat, India. Trials. 2020;21:1–13.
   Google Scholar